ABT—One loud and clear result from today’s HCV abstract—no matter what else happens in the trial in question—is that the AbbVie spinoff is much more than just Humira.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”